¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Verapamil"¿¡ ´ëÇÑ ¿µ¿µ ÀÇÇлçÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
verapamil <drug> A calcium channel blocking drug, used as a coronary vasodilator and antiarrhythmic.
Pharmacologic action: Calcium channel blockade, direct, potent negative chronotrope and inotrope, slows conduction in AV node, systemic and coronary vasodilation.
Uses: Supraventricular tachycardias.
Dose: 2.5 - 5.0 mg IV over 1-2 minutes May repeat at 5.0 - 10 mg every 15-30 minutes until 30 mg total dose.
Onset: 3 - 5 min.
Potential complications: Hypotension due to vasodilation and depressed contractility. Treat with calcium; bradycardia, AV block can be exacerbated, contraindicated with congestive heart failure, synergistic interaction with beta blockers.
Note: Administration of verapamil to a patient with ventricular tachycardia can be lethal. Verapamil can accelerate heart rate and decrease blood pressure, especially in patients with Wolff-Parkinson-White and wide-complex tachycardia.
(12 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á